In vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci.
The MICs and MBCs for 90% of strains tested (MIC90 and MBC90, respectively) of rifampin for 75 clinical isolates of pathogenic coagulase-negative staphylococci (PCNS) were 0.03 and 0.25 microgram/ml, respectively, while the MIC90 and MBC90 of clindamycin were both greater than 25 micrograms/ml. Alth...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1989
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171467/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2719468/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.2.245 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|